相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。High occupational level is associated with poor response to the treatment of depression: A replication study
Laura Mandelli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
On the suitability of medical analogies, from hypertension to broken leg
Georg S. Kranz et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2019)
Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study
Gernot Fugger et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2019)
Major Depression and Comorbid Diabetes - Findings from the European Group for the Study of Resistant Depression
Gernot Fugger et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Prognosis and improved outcomes in major depression: a review
Christoph Kraus et al.
TRANSLATIONAL PSYCHIATRY (2019)
Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study
A. Kautzky et al.
ACTA PSYCHIATRICA SCANDINAVICA (2019)
Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples
Chiara Fabbri et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definition
Diego Hidalgo-Mazzei et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression
Markus Dold et al.
JOURNAL OF CLINICAL PSYCHIATRY (2019)
Switching to Imipramine Versus Add-on Mirtazapine in Venlafaxine-Resistant Major Depression A 10-Week Randomized Open Study
Victor Navarro et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation
C. Fabbri et al.
PHARMACOGENOMICS JOURNAL (2018)
Clinical correlates of augmentation/combination treatment strategies in major depressive disorder
M. Dold et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
Comorbid thyroid disease in patients with major depressive disorder - results from the European Group for the Study of Resistant Depression (GSRD)
Gernot Fugger et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Major Depression and the Degree of Suicidality: Results of the European Group for the Study of Resistant Depression (GSRD)
Markus Dold et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)
Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study
Markus Dold et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Treatment-resistant depression and suicidality
Isidoor O. Bergfeld et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression
Paolo Olgiati et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample
Alexander Kautzky et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Switching the Antidepressant After Nonresponse in Adults With Major Depression: A Systematic Literature Search and Meta-Analysis
Tom Bschor et al.
JOURNAL OF CLINICAL PSYCHIATRY (2018)
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis
Andrea Cipriani et al.
LANCET (2018)
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
Naomi R. Wray et al.
NATURE GENETICS (2018)
Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance
Chiara Fabbri et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2018)
Antidepressant drug-specific prediction of depression treatment outcomes from genetic and clinical variables
Raquel Iniesta et al.
SCIENTIFIC REPORTS (2018)
The Present and Future of Precision Medicine in Psychiatry: Focus on Clinical Psychopharmacology of Antidepressants
Alessandro Serretti
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2018)
Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study
Markus Dold et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2018)
Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT
David Kessler et al.
HEALTH TECHNOLOGY ASSESSMENT (2018)
Evidence-based pharmacotherapy of treatment-resistant unipolar depression
Markus Dold et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2017)
Genetic Contributions of Inflammation to Depression
Jacob Barnes et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance
Chiara Fabbri et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2017)
Escitalopram plasma levels and antidepressant response
Vincenzo Florio et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study
Alexandra Schosser et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2017)
Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines
Michael Bauer et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2017)
Administration of ketamine for unipolar and bipolar depression
Christoph Kraus et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2017)
Clinical and Genetic Predictors of Delayed Remission After Multiple Levels of Antidepressant Treatment: Toward Early Identification of Depressed Individuals for Advanced Care Options
Michael I. Falola et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
A New Prediction Model for Evaluating Treatment-Resistant Depression
Alexander Kautzky et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression
Lucie Bartova et al.
JOURNAL OF ECT (2017)
Clinical characteristics and treatment outcomes of patients with major depressive disorder and comorbid anxiety disorders - results from a European multicenter study
Markus Dold et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2017)
Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials
Markus Dold et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2017)
Personality Disorders in Primary Care: Impact on Depression Outcomes Within Collaborative Care
Kurt B. Angstman et al.
JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH (2017)
Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential
Ryan Bogdan et al.
BIOLOGICAL PSYCHIATRY (2017)
The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study
Markus Dold et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression
F. Hieronymus et al.
MOLECULAR PSYCHIATRY (2016)
Step-wise loss of antidepressant effectiveness with repeated antidepressant trials in bipolar II depression
Jay D. Amsterdam et al.
BIPOLAR DISORDERS (2016)
Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study
Markus Dold et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
High occupational level is associated with poor response to treatment of depression
Laura Mandelli et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment - a European multicentre study
Peter Hoefer et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2016)
Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study
Martina Balestri et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Bipolar II disorder as a risk factor for postpartum depression
Laura Mandelli et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Combining clinical variables to optimize prediction of antidepressant treatment outcomes
Raquel Iniesta et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2016)
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Theo Vos et al.
LANCET (2016)
Testing a machine-learning algorithm to predict the persistence and severity of major depressive disorder from baseline self-reports
R. C. Kessler et al.
MOLECULAR PSYCHIATRY (2016)
Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: A systematic review
Vera De Carlo et al.
PSYCHIATRY RESEARCH (2016)
Machine learning, statistical learning and the future of biological research in psychiatry
R. Iniesta et al.
PSYCHOLOGICAL MEDICINE (2016)
Cross-trial prediction of treatment outcome in depression: a machine learning approach
Adam Mourad Chekroud et al.
LANCET PSYCHIATRY (2016)
Adverse Effects of Second-Generation Antipsychotics as Adjuncts to Antidepressants Are the Risks Worth the Benefits?
Michael E. Thase
PSYCHIATRIC CLINICS OF NORTH AMERICA (2016)
Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases
Lucie Bartova et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression
Alexander Kautzky et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Biomarkers for Psychiatry: The Journey from Fantasy to Fact, a Report of the 2013 CINP Think Tank
Elizabeth Scarr et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Temperament and character profiles in bipolar I, bipolar II and major depressive disorder: Impact over illness course, comorbidity pattern and psychopathological features of depression
Leonardo Zaninotto et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Neuronal cell adhesion genes and antidepressant response in three independent samples
C. Fabbri et al.
PHARMACOGENOMICS JOURNAL (2015)
Dimensions of Delusions in Major Depression: Socio-demographic and Clinical Correlates in an Unipolar-Bipolar Sample
Leonardo Zaninotto et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2015)
Association study of CREB1 polymorphisms and suicidality in MDD: results from a European multicenter study on treatment resistant depression
Laura Carlberg et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2015)
What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram
Daniel Souery et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2015)
Treatment-resistant depression: a challenge for future research
Siegfried Kasper
ACTA NEUROPSYCHIATRICA (2014)
Family history of major depression and residual symptoms in responder and non-responder depressed patients
Alessandro Serretti et al.
COMPREHENSIVE PSYCHIATRY (2014)
MAJOR DEPRESSIVE DISORDER SUBTYPES TO PREDICT LONG-TERM COURSE
Hanna M. van Loo et al.
DEPRESSION AND ANXIETY (2014)
Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors
Florian Seemueller et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2014)
A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine
Stuart A. Montgomery et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
History, background, concepts and current use of comedication and polypharmacy in psychiatry
H. -J. Moeller et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Large-scale genomics unveils the genetic architecture of psychiatric disorders
Jacob Gratten et al.
NATURE NEUROSCIENCE (2014)
PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway
C. Fabbri et al.
PHARMACOGENOMICS JOURNAL (2014)
Contribution of Common Genetic Variants to Antidepressant Response
Katherine E. Tansey et al.
BIOLOGICAL PSYCHIATRY (2013)
A Clinical Risk Stratification Tool for Predicting Treatment Resistance in Major Depressive Disorder
Roy H. Perlis
BIOLOGICAL PSYCHIATRY (2013)
The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder
Peter Hoefer et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Influence of family history of major depression, bipolar disorder, and suicide on clinical features in patients with major depression and bipolar disorder
Alessandro Serretti et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2013)
Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder
D. Amital et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2013)
Variation in the HTR1A and HTR2A genes and social adjustment in depressed patients
Niki Antypa et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Affective temperaments are associated with specific clusters of symptoms and psychopathology: A cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse
Felice Iasevoli et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples
Alessandro Serretti et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients
Raffaella Calati et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Psychotic versus non-psychotic major depressive disorder: A comparative naturalistic study
Massimiliano Buoli et al.
ASIAN JOURNAL OF PSYCHIATRY (2013)
The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder - A European Multicenter Study
A. Schosser et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
European Group for the Study of Resistant Depression (GSRD) - Where have we gone so far: Review of clinical and genetic findings
Alexandra Schosser et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Use of the Hypomania Checklist-32 and the Mood Disorder Questionnaire for detecting bipolarity in 1,051 patients with major depressive disorder
J. K. Rybakowski et al.
EUROPEAN PSYCHIATRY (2012)
Bipolarity and inadequate response to antidepressant drugs: Clinical and psychopharmacological perspective
Janusz K. Rybakowski
JOURNAL OF AFFECTIVE DISORDERS (2012)
Early Switch Strategy in Patients With Major Depressive Disorder A Double-Blind, Randomized Study
Irene Romera et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Depression: an inflammatory illness?
Rajeev Krishnadas et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
The hidden third: improving outcome in treatment-resistant depression
Thomas E. Schlaepfer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2012)
Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression
Julien Mendlewicz et al.
NEUROSCIENCE LETTERS (2012)
Clinical Patterns and Treatment Outcome in Patients with Melancholic, Atypical and Non-Melancholic Depressions
Margalida Gili et al.
PLOS ONE (2012)
Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study
A. John Rush et al.
AMERICAN JOURNAL OF PSYCHIATRY (2011)
Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder
Neslihan Aygun Kocabas et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2011)
Phenomenology of psychotic mood disorders: Lifetime and major depressive episode features
Daniel Souery et al.
JOURNAL OF AFFECTIVE DISORDERS (2011)
Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression
Daniel Souery et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
C. Hiemke et al.
PHARMACOPSYCHIATRY (2011)
No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression
Alessandro Serretti et al.
PSYCHIATRY RESEARCH (2011)
Citalopram versus desipramine in treatment resistant depression: Effect of continuation or switching strategies. A randomized open study
Daniel Souery et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2011)
No evidence for switching the antidepressant: systematic review and meta-analysis of RCTs of a common therapeutic strategy
T. Bschor et al.
ACTA PSYCHIATRICA SCANDINAVICA (2010)
National Trends in Psychotropic Medication Polypharmacy in Office-Based Psychiatry
Ramin Mojtabai et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
MAJOR DEPRESSION: THE IMPORTANCE OF CLINICAL CHARACTERISTICS AND TREATMENT RESPONSE TO PROGNOSIS
Wayne Katon et al.
DEPRESSION AND ANXIETY (2010)
Outcomes of 1014 naturalistically treated inpatients with major depressive episode
Florian Seemueller et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2010)
5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder
Magali Noro et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study
Julien Mendlewicz et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study
Neslihan Aygun Kocabas et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients
Alessandro Serretti et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2009)
The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode
Florian Seemueller et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A STAR*D report
Maurizio Fava et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Factors Predicting Reduced Antidepressant Response: Experience with the SNRI Duloxetine in Patients with Major Depression
Robert H. Howland et al.
ANNALS OF CLINICAL PSYCHIATRY (2008)
Treatment of SSRI-resistant depression: A meta-analysis comparing within-versus across-class switches
George I. Papakostas et al.
BIOLOGICAL PSYCHIATRY (2008)
Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update
Edoardo Spina et al.
CLINICAL THERAPEUTICS (2008)
Prescribing patterns of antidepressants in europe: Results from the Factors Influencing Depression Endpoints Research (FINDER) study
Michael Bauer et al.
EUROPEAN PSYCHIATRY (2008)
Safety of High-intensity Treatment with the Irreversible Monoamine Oxidase Inhibitor Tranylcypromine in Patients with Treatment-resistant Depression
M. Adli et al.
PHARMACOPSYCHIATRY (2008)
Predictors of treatment response and length of stay for inpatients with major depression
I-Chih Cheng et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2007)
Clinical factors associated with treatment resistance in major depressive disorder: Results from a European multicenter study
Daniel Souery et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder:: A systematic review
Henricus G. Ruhe et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Opinion - Gene-environment interactions in psychiatry: joining forces with neuroscience
Avshalom Caspi et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression
David L. Dunner et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression
AJ Rush et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Personality disorder and the outcome of depression: meta-analysis of published studies
G Newton-Howes et al.
BRITISH JOURNAL OF PSYCHIATRY (2006)
Medical risk in patients with bipolar disorder and schizophrenia
John W. Newcomer
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Pharmacogenomics and antidepressant drugs
EB Binder et al.
ANNALS OF MEDICINE (2006)
Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review
M Adli et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2005)
The role of calmodulin as a signal integrator for synaptic plasticity
ZG Xia et al.
NATURE REVIEWS NEUROSCIENCE (2005)
Genetic epidemiology of major depression: Review and meta-analysis
PF Sullivan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
分享论文
